TRU.AX

Healthcare Medical Devices

TruScreen Group Limited

A$0.01

-0.00 -5.00% today

Price History

Not enough data

Key Stats

Market Cap

9.95M

Avg Volume

859,445

52W High

A$0.03

52W Low

A$0.01

Div. Yield

0.0%

Valuation

P/B Ratio

3.92

P/S Ratio

3.52

EV/Revenue

2.59

Margins

Gross Margin 41.0%

Operating Margin (48.1%)

Net Margin (79.8%)

EBITDA Margin 0.0%

Growth & Returns

Revenue Growth (YoY)

120.5%

Return on Equity

(125.4%)

Return on Assets

(44.8%)

Liquidity & Leverage

Current Ratio

3.29

Quick Ratio

2.67

Debt / Equity

0.08

Total Cash

1.46M

Total Debt

200,695

About

TruScreen Group Limited, together with its subsidiaries, develops, manufacture, and sale of cancer detection devices and systems in Mexico, China, Central Asia, Vietnam, Zimbabwe, Indonesia, India, and the Middle East/North Africa. It offers TruScreen cervical cancer screening device, a medical device for identifying and detecting the presence of precancerous and cancerous tissue on the cervix in real time. The company was formerly known as TruScreen Limited and changed its name to TruScreen Group Limited in August 2020. TruScreen Group Limited was incorporated in 2013 and is headquartered in Auckland, New Zealand.